Robert P Favier1, Bart Spee2, Hille Fieten2, Ted S G A M van den Ingh3, Baukje A Schotanus2, Bas Brinkhof2, Jan Rothuizen2, Louis C Penning2. 1. Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, P.O. Box 80154, 3508 TD, Utrecht, The Netherlands. Electronic address: r.p.favier@uu.nl. 2. Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, P.O. Box 80154, 3508 TD, Utrecht, The Netherlands. 3. TCCI Consultancy BV, The Netherlands.
Abstract
BACKGROUND: COMMD1-deficient dogs progressively develop copper-induced chronic hepatitis. Since high copper leads to oxidative damage, we measured copper metabolism and oxidative stress related gene products during development of the disease. METHODS: Five COMMD1-deficient dogs were studied from 6 months of age over a period of five years. Every 6 months blood was analysed and liver biopsies were taken for routine histological evaluation (grading of hepatitis), rubeanic acid copper staining and quantitative copper analysis. Expression of genes involved in copper metabolism (COX17, CCS, ATOX1, MT1A, CP, ATP7A, ATP7B, ) and oxidative stress (SOD1, catalase, GPX1 ) was measured by qPCR. Due to a sudden death of two animals, the remaining three dogs were treated with d-penicillamine from 43 months of age till the end of the study. Presented data for time points 48, 54, and 60 months was descriptive only. RESULTS: A progressive trend from slight to marked hepatitis was observed at histology, which was clearly preceded by an increase in semi-quantitative copper levels starting at 12 months until 42 months of age. During the progression of hepatitis most gene products measured were transiently increased. Most prominent was the rapid increase in the copper binding gene product MT1A mRNA levels. This was followed by a transient increase in ATP7A and ATP7B mRNA levels. CONCLUSIONS: In the sequence of events, copper accumulation induced progressive hepatitis followed by a transient increase in gene products associated with intracellular copper trafficking and temporal activation of anti-oxidative stress mechanisms.
BACKGROUND:COMMD1-deficient dogs progressively develop copper-induced chronic hepatitis. Since high copper leads to oxidative damage, we measured copper metabolism and oxidative stress related gene products during development of the disease. METHODS: Five COMMD1-deficient dogs were studied from 6 months of age over a period of five years. Every 6 months blood was analysed and liver biopsies were taken for routine histological evaluation (grading of hepatitis), rubeanic acid copper staining and quantitative copper analysis. Expression of genes involved in copper metabolism (COX17, CCS, ATOX1, MT1A, CP, ATP7A, ATP7B, ) and oxidative stress (SOD1, catalase, GPX1 ) was measured by qPCR. Due to a sudden death of two animals, the remaining three dogs were treated with d-penicillamine from 43 months of age till the end of the study. Presented data for time points 48, 54, and 60 months was descriptive only. RESULTS: A progressive trend from slight to marked hepatitis was observed at histology, which was clearly preceded by an increase in semi-quantitative copper levels starting at 12 months until 42 months of age. During the progression of hepatitis most gene products measured were transiently increased. Most prominent was the rapid increase in the copper binding gene product MT1A mRNA levels. This was followed by a transient increase in ATP7A and ATP7B mRNA levels. CONCLUSIONS: In the sequence of events, copper accumulation induced progressive hepatitis followed by a transient increase in gene products associated with intracellular copper trafficking and temporal activation of anti-oxidative stress mechanisms.
Authors: Karen Dirksen; Bart Spee; Louis C Penning; Ted S G A M van den Ingh; Iwan A Burgener; Adrian L Watson; Marian Groot Koerkamp; Jan Rothuizen; Frank G van Steenbeek; Hille Fieten Journal: PLoS One Date: 2017-05-01 Impact factor: 3.240
Authors: Jonathan P Mochel; Albert E Jergens; Dawn Kingsbury; Hyun Jung Kim; Martín G Martín; Karin Allenspach Journal: AAPS J Date: 2017-12-12 Impact factor: 3.603
Authors: Xiaoyan Wu; Paul J J Mandigers; Adrian L Watson; Ted S G A M van den Ingh; Peter A J Leegwater; Hille Fieten Journal: J Vet Intern Med Date: 2019-06-29 Impact factor: 3.333
Authors: Hedwig S Kruitwagen; Loes A Oosterhoff; Monique E van Wolferen; Chen Chen; Sathidpak Nantasanti Assawarachan; Kerstin Schneeberger; Anne Kummeling; Giora van Straten; Ies C Akkerdaas; Christel R Vinke; Frank G van Steenbeek; Leonie W L van Bruggen; Jeannette Wolfswinkel; Guy C M Grinwis; Sabine A Fuchs; Helmuth Gehart; Niels Geijsen; Robert G Vries; Hans Clevers; Jan Rothuizen; Baukje A Schotanus; Louis C Penning; Bart Spee Journal: Cells Date: 2020-02-11 Impact factor: 6.600
Authors: Iris Ribitsch; Pedro M Baptista; Anna Lange-Consiglio; Luca Melotti; Marco Patruno; Florien Jenner; Eva Schnabl-Feichter; Luke C Dutton; David J Connolly; Frank G van Steenbeek; Jayesh Dudhia; Louis C Penning Journal: Front Bioeng Biotechnol Date: 2020-08-13
Authors: Sathidpak Nantasanti; Bart Spee; Hedwig S Kruitwagen; Chen Chen; Niels Geijsen; Loes A Oosterhoff; Monique E van Wolferen; Nicolas Pelaez; Hille Fieten; Richard W Wubbolts; Guy C Grinwis; Jefferson Chan; Meritxell Huch; Robert R G Vries; Hans Clevers; Alain de Bruin; Jan Rothuizen; Louis C Penning; Baukje A Schotanus Journal: Stem Cell Reports Date: 2015-10-08 Impact factor: 7.765